With this enhancement in the Chemotherapy Manager, users can create and manage off-plan administrations, allowing for the inclusion of necessary treatments not covered by the plan. This update facilitates the flexible administration of treatments as patient needs evolve.
With this enhancement in the Chemotherapy Manager, users can specify start dates, cycles, and days for ongoing treatments, using both the flowsheet and plan sections. This dual capability ensures accurate and up-to-date treatment timelines, facilitating precise therapy tracking and real-time adjustments.
With this enhancement in the CureMD application, users gain the ability to add appointment notes directly within the UB-04 Charges module, simplifying the documentation process.
With this enhancement in the CureMD application, the Insurance Report displays the patient's registered location, including phone and fax numbers, providing comprehensive patient-related details. This enhances usability by offering more specific information directly within the Insurance Report.
With this enhancement in the CureMD application, a ‘Payer Down Status’ label is visible on the financial overview, allowing biller users to instantly recognize when a payer is experiencing issues. This feature is designed to aid billers in adjusting their actions and maintaining clarity during payer management.
With this enhancement in the CureMD application, the 'F-19 Comments' section on the charge page features a character limit for use in HCFA and EDI submissions. This ensures comments meet submission requirements, reducing claim rejection risks due to character overages.
With this enhancement in the CureMD application, users have the option to exclude appointments with pending payments when viewing a patient's balance at check-in, enabling the accurate collection of true open patient balances from previous Dates of Service (DOS) after plan payments. This feature ensures that only the amounts truly owed by the patient are displayed, enhancing the check-in process.
With this enhancement in the CureMD application, the insurance code(s) field becomes mandatory for Medicare secondary insurance entries, ensuring data accuracy and compliance. This change aligns the validation rules for Medicare secondary insurance with those of Medicare tertiary insurance, enhancing consistency across the platform.
This enhancement allows the user to replace current medications in a patient's treatment plan with biosimilars preferred by their insurance. It ensures the continuity of the treatment by preserving the schedule of the previously consumed drug for the newly replaced biosimilar, while historical treatment data is updated to reflect the change.
This enhancement in the Chemotherapy Manager System has been designed to facilitate the replacement of current medications in a patient's treatment plan with those preferred by their insurance, focusing on the transition from one brand to another, brand to generic drugs, or vice versa. This system ensures that when a drug is replaced due to insurance preferences, the historical data of drug consumption is preserved, reflecting the old medication on past treatment days and the new, replaced medication on future treatment days.
Posted On: Mar 13, 2024
Posted On: Mar 13, 2024
Posted On: Mar 13, 2024
Posted On: Mar 13, 2024
Posted On: Mar 13, 2024
Posted On: Mar 13, 2024